Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Risk Factors Affecting MSC Efficacy in ACLF Patients — Stella

Home/Acute-On-Chronic Liver Failure/Risk Factors Affecting MSC Efficacy in ACLF Patients

View on ClinicalTrials.gov

Recruiting

Back to Acute-On-Chronic Liver Failure trials

Risk Factors Affecting MSC Efficacy in ACLF Patients

Trial locations(1 site)

China

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Key details

Sponsor

Sun Yat-sen University

Enrollment target

~446 participants

Started

October 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.